Results 1 to 10 of about 19,441 (231)

mTOR activity and metabolic reprogramming of CD8+ T cells is impaired under hypoxia and within the multiple myeloma bone marrow. [PDF]

open access: yesBlood Adv
Fulton-Ward T   +15 more
europepmc   +1 more source

Mitochondria dysfunction and increased expression of WNT5A and BNIP3 in tenocytes obtained from patients with tendinopathy. [PDF]

open access: yesJSES Int
Nakagawa Y   +11 more
europepmc   +1 more source

Dual Roles of NIX/BNIP3L in Tumors: Friend or Foe. [PDF]

open access: yesBiology (Basel)
Ge F, Shu J, Liu Z, Zhang H, Wang J.
europepmc   +1 more source

Mitophagy and oxidative stress in chronic kidney disease (Review). [PDF]

open access: yesMol Med Rep
Mushuo Q   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

BNIP3 and Nix: Atypical regulators of cell fate

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
Since their discovery nearly 25 years ago, the BCL-2 family members BNIP3 and BNIP3L (aka Nix) have been labelled 'atypical'. Originally, this was because BNIP3 and Nix have divergent BH3 domains compared to other BCL-2 proteins. In addition, this atypical BH3 domain is dispensable for inducing cell death, which is also unusual for a 'death gene ...
Jared T, Field, Joseph W, Gordon
openaire   +2 more sources

BNIP3 as a Regulator of Cisplatin-Induced Apoptosis

Biochemistry (Moscow), 2020
BNIP3 is a member of Bcl-2 protein family involved in regulation of various forms of cell death. However, its role in these processes remains unclear and varies depending on the type of cancer cells and environmental factors (pH, O2 level, etc.). Here, the role of BNIP3 in apoptosis regulation in lung adenocarcinoma cells was investigated.
A S, Gorbunova   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy